iiinova — where your digital self keeps evolving

Reposted by SIN - Italian Society of Nephrology

ISNkidneycare @theisn.org · 02/10/2026

📖 This weekend don't miss our @kireports.bsky.social #ISNFridaySelection: Target Trial of Glucagon-Like Peptide-1 Agonists versus Dipeptidyl Peptidase-4 Inhibitors and Mortality in Hemodialysis www.kireports.org/article/S2468-024…

002

Reposted by SIN - Italian Society of Nephrology

ASN Publications @asnpublications.bsky.social · 17/09/2026

P-CABs may offer a kidney-safe alternative to PPIs for people with CKD. A large study found P-CAB use was associated with a 37% lower risk of kidney replacement therapy initiation compared with PPIs. kidney.pub/KN1809-10 #ASNKidneyNews

032

Reposted by SIN - Italian Society of Nephrology

ISNkidneycare @theisn.org · 18/09/2026

📖 This weekend don't miss our @kireports.bsky.social #ISNFridaySelection: Prospective Study of Multiparametric Renal MRI for CKD Progression (AFiRM) www.kireports.org/article/S2468-024…

042

Reposted by SIN - Italian Society of Nephrology

ISNkidneycare @theisn.org · 04/09/2026

📖 This weekend don't miss our @kireports.bsky.social #ISNFridaySelection: Anti-CD20 Therapies and Antinephrin Autoantibodies in IgA Nephropathy With Minimal Change Disease www.kireports.org/article/S2468-024…

054

Reposted by SIN - Italian Society of Nephrology

ASN Publications @asnpublications.bsky.social · 04/09/2026

Could a breath test help identify CKD? New research suggests ammonia breath testing may offer a noninvasive approach to screening, although important questions remain: kidney.pub/KN1808-05 #ASNKidneyNews

022

Reposted by SIN - Italian Society of Nephrology

ASN Publications @asnpublications.bsky.social · 22/08/2026

Clinical trials rely on the Cockcroft-Gault equation for kidney function assessment. In this #Perspective, the authors argue that adopting contemporary, race-free eGFR methods could improve patient selection, dosing, and relevance of findings to clinical practice. kidney.pub/JASN1233?... #ASNJASN

041

Reposted by SIN - Italian Society of Nephrology

American Journal of Kidney Diseases @ajkd.bsky.social · 23/08/2026

Associations of Pre-Pandemic CKD With Acute and Post-Acute COVID-19: The C4R Study bit.ly/4whjJON #OpenAccess

001

Reposted by SIN - Italian Society of Nephrology

ISNkidneycare @theisn.org · 24/08/2026

ISN voting members: help shape the future of global kidney care by nominating colleagues for the 2027–29 ISN leadership elections. Nominations are open for President-Elect and 10 Regional Deputy Chair/Council Member positions. Submit by Sept. 23: bit.ly/4vY832l

011

Reposted by SIN - Italian Society of Nephrology

American Journal of Kidney Diseases @ajkd.bsky.social · 20/08/2026

An Uncommon Root Cause of Severe Hypokalemia and Hypertension: A Quiz bit.ly/4w2zjfX (FREE)

011

Reposted by SIN - Italian Society of Nephrology

Critical Care Reviews @criticalcarereviews.com · 19/08/2026

Clinical practice guideline for renal replacement therapy in critically ill patients with acute kidney injury (2026 edition) CCR Journal Watch criticalcarereviews.com/latest-evid…

043

Reposted by SIN - Italian Society of Nephrology

International Society of Renal Nutrition and Metabolism @isrnm-social.bsky.social · 10/08/2026

Can nutrition help slow the progression of chronic kidney disease? Join healthcare professionals from around the world in Berlin to discuss the future of renal nutrition at #ICRNM2026. Berlin, Germany | September 15-19, 2026 Explore the full program and register: icrnm.aey-congresse.de

022

Reposted by SIN - Italian Society of Nephrology

Duke Kidney @dukekidney.bsky.social · 04/08/2026

New ASN Kidney Translation Podcast with Dr Sparks Cardiovascular Kidney Metabolic (CKM) syndrome 🏗️cardio-nephrology service (Kidney360) 🫶cardiorenal benefits of SGLT2i & GLP-1-RAs (JASN) 💻PREVENT risk prediction (CJASN) www.asn-online.org/media/podcast/JA…

Infographic comparing GLP-1 RA and SGLT2i effects on cardiovascular and kidney outcomes in CKM syndrome patients.

001

Reposted by SIN - Italian Society of Nephrology

Kidney International @kidneyint.bsky.social · 27/07/2026

Quantitative serological detection of NELL1 autoantibodies in membranous nephropathy doi.org/10.1016/j.kint.2026.05.017 #MedSky #NephSky #OpenAccess #membranousnephropathy #nephroticsyndrome

042

Reposted by SIN - Italian Society of Nephrology

NKF Nephrology Professionals @nkf-professionals.bsky.social · 26/06/2026

Managing phosphorus remains one of the biggest challenges in dialysis care. This interprofessional discussion covers diet, binders, phosphorus blockers, and practical strategies for managing hyperphosphatemia in 2026. 🎧 bit.ly/3DamjQ9 (Episode 059) Supported by Ardelyx #Hyperphosphatemia

101

Reposted by SIN - Italian Society of Nephrology

kireports.bsky.social @kireports.bsky.social · 24/06/2026

#DeepLearning Morphometric Analysis on Protocol #Biopsies Predicts Future #Graft Function #VisualAbstract by Denisse Arellano www.kireports.org/article/S2468-024…

041

Reposted by SIN - Italian Society of Nephrology

Nephrology Journal Club @nephjc.bsky.social · 21/06/2026

🚨New 🩳 by @nephroseeker.medsky.social eGFRcr, eGFRcys, eGFRcr-cys, mGFR... What does mGFR teach us about estimates and outcomes? #NephSky #MedSky #NephJC www.nephjc.com/news/2026/short/measuredgfr

nephjc.com

NephJC Short: The map and the territory: what measured GFR teaches us about our estimates — NephJC

Is measured GFR more accurate than eGFR for forecasting adverse outcomes?

0149

Reposted by SIN - Italian Society of Nephrology

ASN Publications @asnpublications.bsky.social · 19/06/2026

Research letter in #ASNJASN highlights the need for a comprehensive evaluation of acid-base status in CKD, advocating for integrating blood pH and PCO2 data, along with venous-to-arterial conversion formulas for enhanced clinical phenotyping. twp.ai/9OXm43 Daniel Batlle, MD

041

Reposted by SIN - Italian Society of Nephrology

ASN Publications @asnpublications.bsky.social · 18/06/2026

New Podcast: In this #ASNCJASN podcast, Drs. Roumie and Hung summarize the main findings from their study on "Target Emulation Trial: GLP1RA, SGLT2i, DPP4i for Kidney Outcome Prevention" on behalf of their colleagues. Tune in here: twp.ai/9OWqtU

031

SIN - Italian Society of Nephrology @sinnefro.bsky.social · 12/06/2026

Fresh evidence on kidney stone prevention. A new Annals of Internal Medicine review highlights the role of higher fluid intake, reduced salt and animal protein, and targeted therapies Read the open‑access article: acpjournals.org/doi/10.7326/AN… #Nefrologia #CalcolosiRenale #Nephrology

acpjournals.org

000

SIN - Italian Society of Nephrology @sinnefro.bsky.social · 11/06/2026

Last year at the 66th #SIN2025 Congress, Dr. Luca De Nicola and Dr. Maura Ravera highlighted key updates on CKD screening and holistic care. 👇 Watch the talks 🇮🇹 👉 Screening law & Observatory: youtube.com/watch?v=6F8TBo… 👉 CKD burden & new therapies: youtube.com/watch?v=mgp3tp��

youtube.com

120

Reposted by SIN - Italian Society of Nephrology

KDIGO @kdigo.org · 08/06/2026

The KDIGO B Cell Controversies Conference Report is now available on the KDIGO and KI websites! The report examines advances that could reshape treatment for kidney diseases. Download: kdigo.co/B-Cell-Confe... Read in KI: kdigo.co/B-Cell-Confe... More resources: kdigo.org/conferences/...

041

Reposted by SIN - Italian Society of Nephrology

American Journal of Kidney Diseases @ajkd.bsky.social · 08/06/2026

Advice for Living With Hemodialysis: A Qualitative Study of Older Patients and Their Care Partners bit.ly/4dWnlPx (OPEN ACCESS)

032

Reposted by SIN - Italian Society of Nephrology

JAMA Internal Medicine @jamainternalmed.com · 06/06/2026

From JAMA: In this observational study of adults in Stockholm, measured GFR (mGFR) values below 90 mL/min/1.73 m² were associated with progressively higher rates of #mortality, #kidney failure, #heart failure, acute kidney injury, and major #cardiovascular events. ja.ma/4o8zzHY

JAMA article: 'Measured & Estimated Glomerular Filtration Rates & Risk of Adverse Health Outcomes.' Figure 1 displays density & box plots for GFR distribution using mGFR, eGFRcr, eGFRcys, & eGFRcr-cys. GFR range: 15-120 mL/min/1.73 m². Published June 4, 2026.

032

Reposted by SIN - Italian Society of Nephrology

ADTKD Vision Cure @adtkd-muc1.bsky.social · 05/06/2026

#ERA26 Jan Halbritter on the challenges in diagnosing #ADTKD #MUC1, but online tool #VNtyper 2 makes it much easier. 👏 @hassansaei.bsky.social @erknet.bsky.social

Blindspot of genetic testing: ADTKD MUC1

043

Reposted by SIN - Italian Society of Nephrology

JAMA @jama.com · 05/06/2026

Among adults with chronic #kidney #disease (#CKD) due to glomerular diseases, finerenone slowed eGFR decline, reduced albuminuria, and lowered risk of kidney failure, with consistent benefits across disease subtypes and in those using #SGLT2 inhibitors. #ERA26 ja.ma/3QpbH6y

JAMA study on finerenone for chronic kidney disease in 903 patients with glomerular diseases. Finerenone slowed kidney function loss, with an eGFR slope of -3.50 mL/min/1.73 m²/year vs placebo's -4.23, and reduced kidney failure risk (HR 0.74).

051

Reposted by SIN - Italian Society of Nephrology

NEJM.org @nejm.org · 05/06/2026

In this 104-week trial involving patients with primary membranous nephropathy, the type II anti-CD20 antibody obinutuzumab was superior to the calcineurin inhibitor tacrolimus in inducing complete remission. Full phase 3 MAJESTY trial results: nej.md/4dZsVPD #ERA26

A line graph from an article published in the New England Journal of Medicine compares obinutuzumab and tacrolimus in treating primary membranous nephropathy over 104 weeks. The y-axis represents the percentage of patients relapse‑free, while the x-axis represents weeks. The graph shows two lines, one for obinutuzumab and another for tacrolimus. The image mentions the European Renal Association Congress at the top.

0102

Reposted by SIN - Italian Society of Nephrology

KDIGO @kdigo.org · 01/06/2026

Attending #ERA26 in Glasgow? Don't miss the KDIGO symposium "What's New with KDIGO" on Saturday, June 6, 08:30–10:30 BST. Learn more: kdigo.co/ERA26-KDIGO-... Topics include the upcoming Diabetes Guideline, evolving CKM framework, insights from the KDIGO B Cell Conference, and the latest in IgAN.

042

Reposted by SIN - Italian Society of Nephrology

ASN Publications @asnpublications.bsky.social · 28/05/2026

The May issue of Kidney360 is now available online! Topics covered this month include: - A behavioral nudge to discuss CKM - Advances in mouse models of CKD to reduce fibrosis - and more Check out the issue here: kidney.pub/K360-0526 #ASNKidney360 Cover by Qiu et al.

001

Reposted by SIN - Italian Society of Nephrology

American Journal of Kidney Diseases @ajkd.bsky.social · 28/05/2026

Special Collection: These articles highlight recent research published in AJKD on developments in kidney transplantation and its impact on donors and recipients. bit.ly/2wAeRIo (FREE until August 20, 2026)

241

Reposted by SIN - Italian Society of Nephrology

Eric Goffin @er-goffin.bsky.social · 26/04/2026

👉Integrated home #dialysis model facilitates #transition from #peritoneal dialysis to self-care #hemodialysis: evidence from our 🇧🇪 cohort at Clin univ St-Luc 🔗 DOI:10.1093/joneph/aajag004 Key message: A “PD first → self-care HD second” pathway is feasible and helps preserve patient autonomy.

021

Reposted by SIN - Italian Society of Nephrology

NKF Nephrology Professionals @nkf-professionals.bsky.social · 20/03/2026

Busy schedule? SCM26 fits your timeline. Register for SCM On-Demand to watch recordings of most sessions, available 48 hours after they occur. Learn on your schedule: www.kidney.org/spring-clini... #NKFClinicals #MedEd #Nephrology #NephSky

011

Reposted by SIN - Italian Society of Nephrology

International Society of Glomerular Disease @isgd.bsky.social · 20/03/2026

💡Join us for the RPA/ISGD Clinical Trials Bootcamp - designed for community nephrologists to establish robust research programs. Register here: bit.ly/RPA-ISGD-CTB Including: ✔️ Building the Business Plan & ROI ✔️ Executing the Plan ✔️ Support & Logistics ✔️ Strategies for varied practice settings

201

Reposted by SIN - Italian Society of Nephrology

Kidney International @kidneyint.bsky.social · 20/03/2026

Commentary The expanding role of complement inhibitors in the treatment of IgA nephropathy doi.org/10.1016/j.kint.2025.12.015 Original article: doi.org/10.1016/j.kint.2025.11.017 #MedSky #NephSky #IgAN @ucm.es

033

Reposted by SIN - Italian Society of Nephrology

ASN Publications @asnpublications.bsky.social · 17/03/2026

Can comprehensive genetic testing effectively identify the underlying genetic causes of pediatric kidney cysts and improve diagnostic accuracy and clinical management, particularly in children with or without a known family history of kidney disease? Read #ASNCJASN kidney.pub/CJASN1027

002

Reposted by SIN - Italian Society of Nephrology

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 13/03/2026

The newest journal Kidney International Case Reports KICR launched by the international Society of Nephrology has just put out its inaugural group of articles (in press) & an editorial. Do read them at this link 👉 www.sciencedirect.com/journal/kidn... @theisn.org @christosargyrop.bsky.social

074

Reposted by SIN - Italian Society of Nephrology

ASN Publications @asnpublications.bsky.social · 14/03/2026

JASN encourages investigators to submit their late-breaking clinical trial (LBCT) manuscripts for rapid consideration and peer review and, if accepted, online publication concurrent with #ERA26. More info: bit.ly/JASNLBCT

001

Reposted by SIN - Italian Society of Nephrology

ASN Publications @asnpublications.bsky.social · 10/03/2026

Integration of connected dialysis machines, remote patient monitoring, and AI-driven analytics (digital dialysis) offers a path to more robust, personalized, and green online hemodiafiltration (HDF) delivery. Read more in #ASNKidneyNews kidney.pub/KN1803-14

111

Reposted by SIN - Italian Society of Nephrology

kireports.bsky.social @kireports.bsky.social · 25/02/2026

Markers of #Mineral #Metabolism in Children with CKD Stages 2-5D #VisualAbstract by Brian Rifkin www.kireports.org/article/S2468-024…

042

Reposted by SIN - Italian Society of Nephrology

UK Kidney Association @ukkidney.org · 25/02/2026

📑 Comments are invited on a draft clinical practice guideline on the long-term management of kidney transplant recipients, covering follow-up, immunosuppression, rejection, cardiovascular risk, infection, bone health, malignancy & reproductive issues. Find out more: ow.ly/5nK150Yka2y

111

Reposted by SIN - Italian Society of Nephrology

kireports.bsky.social @kireports.bsky.social · 20/02/2026

The Pathophysiological Mechanism of #Beni-koji #Choleste-Help or #Puberulic Acid–Induced Kidney Injury #AKI #VisualAbstract by @krishnadoctor1 www.kireports.org/article/S2468-024…

032

Reposted by SIN - Italian Society of Nephrology

American Journal of Kidney Diseases @ajkd.bsky.social · 15/02/2026

Special Collection: World Kidney Day Accelerometry-Derived Physical Activity Levels and Mortality in Hemodialysis Patients: A Prospective Cohort Study bit.ly/4j9tE3e

Correlations between PA parameters and step counts (a) A curvilinear correlation was found between MPA and step counts (Adjusted R-squared=0.77; P for non-linearity<0.001). (b) There was a negligible correlation between LPA and step counts (Adjusted R-squared=0.19; P for non-linearity<0.001), indicating that steps do not accurately reflect LPA. Nonlinearity was tested by comparing a model that included a quadratic term with one that included only a linear term using a likelihood ratio test. A quadratic curve (a) and Lowess curve (b) were fitted to visualize the relationships between the PA parameters and step counts. Abbreviations: PA, physical activity; MPA, moderate-intensity physical activity; LPA, light-intensity physical activity

031

Reposted by SIN - Italian Society of Nephrology

NKF Nephrology Professionals @nkf-professionals.bsky.social · 12/02/2026

Dialysis is a miracle—but have we begun to take it for granted? This episode challenges us to rethink how dialysis has shaped nephrology’s priorities, innovation, and identity. 🎧 bit.ly/3DamjQ9 #KidneyCommute #Dialysis #Medical #Nephrology

Reposted by SIN - Italian Society of Nephrology

Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 11/02/2026

Simultaneous initiation of finerenone and empagliflozin was effective and well tolerated among CONFIDENCE study participants from Asia, consistent with the overall population ca. 2026 from @asnpublications.bsky.social #Nephpearls #NephSky 👉 pubmed.ncbi.nlm.nih.gov/40965042/

021

Reposted by SIN - Italian Society of Nephrology

Michael S. Balzer @balzer-lab.org · 03/02/2026

Classic Fred Luft #Nephrology 101 editorial on a study testing the effect of potassium supplement on natriuresis: Eliminating sodium with potassium 🔗 academic.oup.com/ndt/article/... #NephSky #MedSky 🧪

186

Reposted by SIN - Italian Society of Nephrology

NDT @ndt-era.bsky.social · 27/01/2026

Risk-based referral model to nephrologist specialist care in Stockholm doi.org/10.1093/ndt/...

012

Reposted by SIN - Italian Society of Nephrology

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 22/01/2026

#NephGR tomorrow! @sbrimble.bsky.social on TMA in cancer and the St Joe’s Hamilton onconephrology program #NephSky

064